We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

DYMIND BIOTECHNOLOGY

Dymind designs, manufactures and sells a range of auto hematology analyzers and home ventilator. The company also off... read more Featured Products: More products

Download Mobile App





Dymind Presents Advanced Automatic Hematology Analysis Line

By LabMedica International staff writers
Posted on 06 Feb 2025

Dymind Biotechnology (Shenzhen, China) is presenting its comprehensive range of healthcare solutions at Medlab Middle East 2025, covering the fields of hematology, coagulation, immunoassay, POCT and veterinary. More...

Dymind is presenting the DH-8000 advanced hematology analysis workstation that provides a comprehensive testing solution for whole blood, capillary blood, body fluids, and pre-diluted samples. It is designed to enhance the user's experience in high-volume sample testing, by minimizing manual intervention and maximizing efficiency. Dymind is also showcasing the upgraded DH-800 auto hematology analyzer with AI technology that provides more accurate and efficient diagnosis. Also featured at the event is the MF1280 novel multiplex platform for allergy and autoimmunity testing that delivers rapid results for all tested items within a single test portfolio, significantly increasing diagnostic efficiency.

At the 2025 edition of Medlab Middle East, Dymind is highlighting the CA1200 fully automated coagulation analyzer that combines the optical and mechanical methods for clotting assays, while being able to intelligent switch from two methods when an abnormal sample is detected, to ensure both test accuracy and cost-effectiveness. In addition, Dymind is showcasing the innovative DP-H50 automatic 5-part hematology analyzer that integrates immunoassay and chemistry. With capabilities for joint tests in CBC, immunofluorescence, colloidal gold, and the chemistry module, the DP-H50 offers 5 test modes with single-package reagents to meet diverse demands. Among its veterinary solutions, Dymind is showcasing the automatic AI morphology analyzer, the D-wise, 5-part automatic hematology analyzer with RET, DM61 Vet, and DP-H10 Vet POCT hematology analyzer.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The updated CRC screening guidance adds a stool RNA test and an updated stool DNA test to the menu of preferred options (image credit: Adobe Stock)

Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests

Colorectal cancer is the second-leading cause of cancer death in the United States and claimed an estimated 55,000 lives in 2026. Incidence is rising among adults younger than 50, even as overall mortality... Read more

Immunology

view channel
Image: Study design for analysis of monocyte phenotype, function, and metabolism (Gráinne Jameson et al., Journal of Infection (2026). DOI: 10.1016/j.jinf.2026.106755)

Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response

Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.